Regadenoson: Review of its established role in myocardial perfusion imaging and emerging applications

Guru Palani, Karthikeyan Ananthasubramaniam

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Myocardial perfusion imaging is a well-established noninvasive modality for the diagnosis and prognosis of coronary artery disease. The pharmacologic stress agents adenosine and dipyridamole are widely used in imaging studies, but cause undesirable side effects, like atrioventricular block and bronchospasm, due to their nonselective adenosine receptor activation. Furthermore, the mode of administration of these agents as a bolus infusion is less preferred. Regadenoson, an A2A adenosine receptor selective pharmacologic stress agent was approved in 2008 and is widely used instead of adenosine and dipyridamole. This article reviews regadenosons structure, mechanism of action, advantages over adenosine and dipyridamole, and its role in various patient populations undergoing stress perfusion imaging. Emerging applications where regadenoson could be of potential use are also explored.

Original languageEnglish (US)
Pages (from-to)42-48
Number of pages7
JournalCardiology in Review
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Myocardial Perfusion Imaging
Dipyridamole
Adenosine
Adenosine A2A Receptors
Bronchial Spasm
Purinergic P1 Receptors
Perfusion Imaging
Atrioventricular Block
Coronary Artery Disease
Population
regadenoson

Keywords

  • adenosine
  • chronic kidney disease
  • chronic obstructive pulmonary disease
  • coronary artery disease
  • coronary flow reserve
  • dipyridamole
  • pharmacologic stress myocardial perfusion imaging
  • regadenoson
  • stress echocardiography

Cite this

Regadenoson : Review of its established role in myocardial perfusion imaging and emerging applications. / Palani, Guru; Ananthasubramaniam, Karthikeyan.

In: Cardiology in Review, Vol. 21, No. 1, 01.01.2013, p. 42-48.

Research output: Contribution to journalReview article

@article{49c68559f53a4c71abcc59cd43bc8c83,
title = "Regadenoson: Review of its established role in myocardial perfusion imaging and emerging applications",
abstract = "Myocardial perfusion imaging is a well-established noninvasive modality for the diagnosis and prognosis of coronary artery disease. The pharmacologic stress agents adenosine and dipyridamole are widely used in imaging studies, but cause undesirable side effects, like atrioventricular block and bronchospasm, due to their nonselective adenosine receptor activation. Furthermore, the mode of administration of these agents as a bolus infusion is less preferred. Regadenoson, an A2A adenosine receptor selective pharmacologic stress agent was approved in 2008 and is widely used instead of adenosine and dipyridamole. This article reviews regadenosons structure, mechanism of action, advantages over adenosine and dipyridamole, and its role in various patient populations undergoing stress perfusion imaging. Emerging applications where regadenoson could be of potential use are also explored.",
keywords = "adenosine, chronic kidney disease, chronic obstructive pulmonary disease, coronary artery disease, coronary flow reserve, dipyridamole, pharmacologic stress myocardial perfusion imaging, regadenoson, stress echocardiography",
author = "Guru Palani and Karthikeyan Ananthasubramaniam",
year = "2013",
month = "1",
day = "1",
doi = "10.1097/CRD.0b013e3182613db6",
language = "English (US)",
volume = "21",
pages = "42--48",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Regadenoson

T2 - Review of its established role in myocardial perfusion imaging and emerging applications

AU - Palani, Guru

AU - Ananthasubramaniam, Karthikeyan

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Myocardial perfusion imaging is a well-established noninvasive modality for the diagnosis and prognosis of coronary artery disease. The pharmacologic stress agents adenosine and dipyridamole are widely used in imaging studies, but cause undesirable side effects, like atrioventricular block and bronchospasm, due to their nonselective adenosine receptor activation. Furthermore, the mode of administration of these agents as a bolus infusion is less preferred. Regadenoson, an A2A adenosine receptor selective pharmacologic stress agent was approved in 2008 and is widely used instead of adenosine and dipyridamole. This article reviews regadenosons structure, mechanism of action, advantages over adenosine and dipyridamole, and its role in various patient populations undergoing stress perfusion imaging. Emerging applications where regadenoson could be of potential use are also explored.

AB - Myocardial perfusion imaging is a well-established noninvasive modality for the diagnosis and prognosis of coronary artery disease. The pharmacologic stress agents adenosine and dipyridamole are widely used in imaging studies, but cause undesirable side effects, like atrioventricular block and bronchospasm, due to their nonselective adenosine receptor activation. Furthermore, the mode of administration of these agents as a bolus infusion is less preferred. Regadenoson, an A2A adenosine receptor selective pharmacologic stress agent was approved in 2008 and is widely used instead of adenosine and dipyridamole. This article reviews regadenosons structure, mechanism of action, advantages over adenosine and dipyridamole, and its role in various patient populations undergoing stress perfusion imaging. Emerging applications where regadenoson could be of potential use are also explored.

KW - adenosine

KW - chronic kidney disease

KW - chronic obstructive pulmonary disease

KW - coronary artery disease

KW - coronary flow reserve

KW - dipyridamole

KW - pharmacologic stress myocardial perfusion imaging

KW - regadenoson

KW - stress echocardiography

UR - http://www.scopus.com/inward/record.url?scp=84871733663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871733663&partnerID=8YFLogxK

U2 - 10.1097/CRD.0b013e3182613db6

DO - 10.1097/CRD.0b013e3182613db6

M3 - Review article

C2 - 22643345

AN - SCOPUS:84871733663

VL - 21

SP - 42

EP - 48

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 1

ER -